National MRI more than a marketplace, a workflow solution

Stephen Hampson, Investment Director, Oxford Capital

Medical scans are a critical source of information for diagnosis and treatment and waiting times can lead to enormous anxiety and impact the time taken to receive essential treatment.  While increasingly, medical imaging is seen as a key piece of information for clinicians, there is a clear need to facilitate patient access to medical scans in a way that supports and enhances the health system. Digital health company, National MRI (nMRI) has taken on this challenge and we recently co-led a Seed funding round to accelerate their roll-out. We wanted to share some thoughts on why we chose to back the team and why we believe their future growth trajectory is looking so promising:

A significant value-add business model

Multi-sided business models are hard to assess and very hard to get right but have the potential for explosive growth. National MRI connects several elements of an existing marketplace; sites with imaging machines and spare imaging capacity with patients that would rather pay than wait. They have developed a two-sided model because they need to recruit both scanning sites and patients. This means managing complexity to find the balance; too few sites and the waiting time increases, too few patients and the sites don’t make enough revenue. The location of each site is also important to minimise the distance patients will need to travel to get a scan.

Although nMRI appears to be a simple marketplace, connecting consumers of scans to providers, it is more specifically a vertical, service-oriented market. A solution that involves connecting multiple users enabling high-value collaboration in a regulation-compliant way. As well as the patient and scanning centre, the GP and radiologist also need to be involved.  Users require an efficient workflow solution, that will allow them to interact, collaborate, and transact on the same platform. This reduces costs and leads to a higher quality of service with increased overall value for all participants.

Strong industry (and consumer?) drivers

Long wait times for scans aren’t caused only by the pandemic. There is a growing demand to get the valuable information provided by a medical scan into the diagnostic process more quickly, producing a faster diagnosis and pathway to treatment. New imaging access methods will only add to this opportunity.

Great people with dynamic capability

Even with a great business model and a growing market, you need the right team to pull it off. At Oxford Capital we prioritise backing founders. We look for deep industry knowledge and relentless energy to come up with ideas on how to grow the business. The National MRI team has this in abundance. A winning formula when combined with execution ability.

They also have another key attribute that makes them standout – dynamic capability. A term found more often in academic literature than business circles, but a critical skill nonetheless. The ability to read the wider ecosystem and predict what is changing and understand the causality – what actions or events will cause what effect.  In nMRI, this goes beyond the management team, the founders have been able to attract a strong list of investors from the industry, all with deep connections and experience bringing a strong capacity to respond effectively to new factors, ensuring the company can maintain and increase value over time.

What’s next for National MRI?

While the business continues to scale its UK operation, the latest funding round will also fuel its international expansion with plans to launch in the USA and Germany under the SCAN.com brand name. The company is also working to build its B2B business model, targeting leading health insurance companies and new preventative services in the UK such as FullBodyScan.com.

We’re looking forward to working with co-founders Charlie and Oli and the whole team to support their growth journey going forwards.

Estimated reading time: 2 min

 

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.

What are the key risks?

  1. You could lose all the money you invest
    1. If the business you invest in fails, you are likely to lose 100% of the money you invested. Most start-up businesses fail.
  2. You are unlikely to be protected if something goes wrong
    1. Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here.
    2. Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here.
  3. You won’t get your money back quickly
    1. Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.
    2. The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.
    3. If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.
  4. Don’t put all your eggs in one basket
    1. Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.
    2. A good rule of thumb is not to invest more than 10% of your money in high-risk investments. https://www.fca.org.uk/investsmart/5-questions-ask-you-invest
  5. The value of your investment can be reduced
    1. The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.
    2. These new shares could have additional rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

 

If you are interested in learning more about how to protect yourself, visit the FCA’s website here.